Early Value Assessment (EVA) framework The National Institute for Health and Care Excellence (NICE) has released two new guidance documents... Read more
Category: Uncategorized
IGC Pharma expands Alzheimer’s clinical network to New York City
Strategic site expansion in Brooklyn IGC Pharma has officially added Integrative Clinical Trials, located in Brooklyn, New York, as a... Read more
Mendra launches with $82M Series A to modernize rare disease treatment
AI-driven operational model Mendra, a San Francisco-based biotechnology startup, has officially emerged from stealth after securing $82 million in a... Read more
China approves new targeted therapy for advanced gastric cancer
Expansion of treatment indications in China On January 22, 2026, China’s National Medical Products Administration (NMPA) officially approved Enhertu (trastuzumab... Read more
Corxel Pharmaceuticals secures $287m to advance cardiometabolic pipeline
Major financial milestone via Series D1 funding On January 23, 2026, Corxel Pharmaceuticals announced the closure of a $287 million... Read more
Update on Infectious Disease Trends in Ho Chi Minh City (Early 2026)
Positive downward trend in infection rates As of the third week of 2026, Ho Chi Minh City has reported a... Read more
United States officially concludes withdrawal from WHO
Termination of relations and resource withdrawal On January 23, the U.S. Department of Health and Human Services (HHS) announced the... Read more
Expansion of free vaccines in the National Expanded Program on Immunization
Nationwide rollout of Rota vaccine As of January 2026, Vietnam has officially implemented the nationwide distribution of free Rotavirus vaccines... Read more
Kuva Labs Acquires Lisata Therapeutics to Expand Cancer Diagnostic and Therapeutic Pipeline
Kuva Labs, a specialist in cancer imaging, has entered into a binding agreement to acquire Lisata Therapeutics, a biotech firm... Read more









